Doctor Oscar Westin

Doctor Oscar Westin

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Oscar Westin graduated from Umeå University, Sweden, in 2014. He defended his PhD dissertation on cardiac amyloidosis in early 2023 at Copenhagen University, Denmark, and began his cardiology residency shortly thereafter. He has clinical experience in patients with cardiac amyloidosis from his own screening studies and from working as a sub-investigator for the Apollo-B trial and the Cardio-TTRansform trial.

Presentations

Screening reveals high prevalence of cardiac amyloidosis 5-15 years after surgery for bilateral carpal tunnel syndrome: The CACTUS-R study

Event: Heart Failure 2022

Topic: Clinical

Session: Myocardial disease: clinical characterization and therapeutical progress

Access

Carpal tunnel syndrome - a marker for amyloidosis and heart failure after pacemaker implantation?

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure patient profile and outcome 2

Access

Upsurge in diagnosed cardiac amyloidosis: a nationwide analysis

Event: Heart Failure 2021

Topic: Epidemiology, Prognosis, Outcome

Session: ePoster session

Access

Soluble urokinase plasminogen activator receptor (suPAR) is an independent risk factor for stroke in patients with atrial fibrillation.

Event: ESC Congress 2018

Topic: Stroke in Atrial Fibrillation

Session: Atrial fibrillation - epidemiology

Access

Doctor Oscar Westin

Biography

Contributor content

Screening reveals high prevalence of cardiac amyloidosis 5-15 years after surgery for bilateral carpal tunnel syndrome: The CACTUS-R study

Carpal tunnel syndrome - a marker for amyloidosis and heart failure after pacemaker implantation?

Upsurge in diagnosed cardiac amyloidosis: a nationwide analysis

Soluble urokinase plasminogen activator receptor (suPAR) is an independent risk factor for stroke in patients with atrial fibrillation.

ESC 365 is supported by